Search

everythinglearnresearchcommunity

for

Search:↓

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Some new oral anticoagulants may also cause hair loss and might not be better than traditional ones for preventing hair loss.

Using a special laser can improve how well hair loss treatments get into the skin and hair follicles.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Ultrasound is a useful, non-invasive tool in dermatology for diagnosing skin conditions and guiding treatments, but it has some limitations.

Platelet-rich plasma (PRP) treatment has been found effective in promoting hair growth for alopecia patients, with minimal side effects like temporary pain and redness.

Moderately high prolactin levels do not cause hair loss in women.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Platelet-Rich Plasma and stem cell therapy can increase hair count and density, but the best method for preparation and treatment still needs to be determined.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

PRP and cell therapies may help with hair loss, but more research is needed.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Early diagnosis and treatment, like topical minoxidil, can prevent hair loss in children.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

A new model using mice with human hair follicles helps better understand hair loss from chemotherapy.

The document concludes that a thorough history, physical exam, and specific tests are crucial for diagnosing and managing hair loss effectively.

Trichodynia is a painful scalp condition not directly linked to the amount or type of hair loss and may involve psychological factors, with treatments showing mixed results.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

New biopsy techniques and tools improve alopecia diagnosis, and both too much and too little selenium can cause hair loss.

The review suggests limited treatments for common hair loss conditions, with potential for future improvements.

The document explains the genetic causes and characteristics of inherited hair disorders.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

The conclusion suggests that focusing on certain cellular pathways may improve the prevention and repair of hair loss caused by radiotherapy.

Scalp cooling can help prevent hair loss from chemotherapy, but treatment should be tailored to the individual and more research is needed.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.